World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
13642
World Ranking
3034
National Ranking
1423

Overview

Andrea A. Zachary is affiliated with Johns Hopkins University School of Medicine in the United States. Their research spans multiple fields with a focus on medicine, biochemistry, genetics, and molecular biology. Within these broader fields, their specific subfields include infectious diseases, oncology, and genetics.

The scientist's work primarily addresses topics related to SARS-CoV-2 and COVID-19 research, cancer immunotherapy and biomarkers, as well as inflammatory bowel disease. These themes represent the core focus areas of their scholarly output.

Among the publications attributed to Andrea A. Zachary is the paper titled P444 COVID-19 risk factors, infection course and vaccination among patients with inflammatory bowel disease based on a Hungarian cohort, published in 2022 in the Journal of Crohn's and Colitis.

Frequent co-authors in their research collaborations include Klaudia Farkas, Mária Matúz, D Kata, Imre Földesi, and T Resál. These collaborative efforts suggest an interdisciplinary approach involving multiple contributors to the study of complex medical and biological questions.

Their work has been published most notably in the Journal of Crohn's and Colitis. This venue aligns with the scientist's focus on inflammatory bowel disease and related clinical issues within gastroenterology and immunology.

  • SARS-CoV-2 and COVID-19 Research
  • Cancer Immunotherapy and Biomarkers
  • Inflammatory Bowel Disease

  • P444 COVID-19 risk factors, infection course and vaccination among patients with inflammatory bowel disease based on a Hungarian cohort, 2022, Journal of Crohn's and Colitis

  • Klaudia Farkas
  • Mária Matúz
  • D Kata
  • Imre Földesi
  • T Resál

  • Journal of Crohn's and Colitis

Best Publications

  • Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups

    B. Sis;M. Mengel;M. Haas;R. B. Colvin

  • Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.

    Brian D. Tait;Caner Süsal;Howard M. Gebel;Peter W. Nickerson

  • PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE RECIPIENTS

    Robert A. Montgomery;Andrea A. Zachary;Lorraine C. Racusen;Mary S. Leffell

  • The Use of Antibody to Complement Protein C5 for Salvage Treatment of Severe Antibody‐Mediated Rejection

    J. E. Locke;C. M. Magro;A. L. Singer;D. L. Segev

  • ABO incompatible renal transplantation: a paradigm ready for broad implementation.

    Robert A. Montgomery;Jayme E. Locke;Karen E. King;Dorry L. Segev

  • Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation.

    Robert A. Montgomery;Andrea A. Zachary;Lloyd E. Ratner;Dorry L. Segev

  • Tumor Regression and Allograft Rejection after Administration of Anti–PD-1

    Evan J. Lipson;Serena M. Bagnasco;Jack Moore;Sekwon Jang

  • Increased frequency of DRB1*11:01 in anti–hydroxymethylglutaryl‐coenzyme A reductase–associated autoimmune myopathy

    Andrew L. Mammen;Daniel Gaudet;Diane Brisson;Lisa Christopher-Stine

  • Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients.

    Andrea A. Zachary;Robert A. Montgomery;Lloyd E. Ratner;Millie Samaniego-Picota

  • Transplanting patients with a positive donor-specific crossmatch: a single center's perspective.

    Robert A. Montgomery;Andrea A. Zachary

  • The role of donor-specific HLA alloantibodies in liver transplantation.

    J.G. O'Leary;A.J. Demetris;L.S. Friedman;Howard Gebel

  • Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers.

    E. R. Rodriguez;Diane V. Skojec;Carmela D. Tan;Andrea A. Zachary

  • Quantifying the risk of incompatible kidney transplantation: a multicenter study.

    B. J. Orandi;J. M. Garonzik-Wang;A. B. Massie;A. A. Zachary

  • Using real data for a virtual crossmatch

    Andrea A. Zachary;Jeffrey T. Sholander;Julie A. Houp;Mary S. Leffell

  • HLA in transplantation.

    Robert A. Montgomery;Vasishta S. Tatapudi;Mary S. Leffell;Andrea A. Zachary

  • The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection

    J. E. Locke;A. A. Zachary;M. Haas;J. K. Melancon

  • Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers.

    Daniel S. Warren;Andrea A. Zachary;Christopher J. Sonnenday;Karen E. King

  • Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution.

    Andrea A. Zachary;Donna P. Lucas;Barbara Detrick;Mary S. Leffell

  • Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes.

    William M. Baldwin;Milagros Samaniego-Picota;Edward K. Kasper;Adam M. Clark

  • Proinflammatory Events Are Associated with Significant Increases in Breadth and Strength of HLA‐Specific Antibody

    J. E. Locke;A. A. Zachary;D. S. Warren;D. L. Segev

  • Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation

    B. E. Lonze;A. A. Zachary;C. M. Magro;N. M. Desai

Frequent Co-Authors

Robert A. Montgomery
Robert A. Montgomery New York University
Dorry L. Segev
Dorry L. Segev Johns Hopkins University
Lorraine C. Racusen
Lorraine C. Racusen Johns Hopkins University School of Medicine
John Hart
John Hart University of Illinois at Urbana-Champaign
Mark Haas
Mark Haas Cedars-Sinai Medical Center
William M. Baldwin
William M. Baldwin Cleveland Clinic Lerner College of Medicine
Hamid Rabb
Hamid Rabb Johns Hopkins University
Stanley C. Jordan
Stanley C. Jordan Cedars-Sinai Medical Center
William H. Hildebrand
William H. Hildebrand University of Oklahoma Health Sciences Center
Elaine F. Reed
Elaine F. Reed University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology opens doors to various specialized healthcare roles, many of which can be enhanced through advanced online education. For those interested in psychiatric care, exploring the best pmhnp programs online can provide strong clinical placement opportunities, ensuring a solid foundation in patient-centered mental health nursing.

Affordability is also a crucial factor for many students. Programs like the cheapest pmhnp certificate programs offer accessible pathways to certification without compromising quality, making them ideal for working professionals seeking advancement.

Financial considerations extend beyond education; understanding how much do dnp nurses make helps graduates evaluate return on investment and plan their future career steps effectively.

Additionally, immunology professionals aiming to broaden their expertise can benefit from certifications such as acute care certification for fnp, which facilitates transitions to advanced practice roles in acute care settings, enhancing both skills and marketability.

Best Scientists Citing Andrea A. Zachary

Trending Scientists

Recently Published Articles